$ALKEM
Alkem Medtech Private Limited executed a First Supplementary Agreement to acquire a controlling 51-55% stake in Occlutech Holding AG, a Swiss cardiac structural implant company. This amendment brings the acquisition closer to completion, marking $ALKEM 's significant expansion into the medtech sector.
#WatchOutFor#StockInNews#EquityResearch#MacroViews#FundamentalViews
602 likes·25 comments

















